Search

everythinglearnresearchcommunity

for

Search:↓

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Sebocytes play a key role in controlling androgen levels in human skin.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Glioblastoma cells can make androgens, which might help the tumor grow.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

Minoxidil may help treat hair loss by reducing the activity of a specific enzyme linked to baldness.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Different skin cells process testosterone differently, and certain drugs can change this process, possibly helping treat acne and hair loss.

The research identified two types of keratinocytes in chicken scales: one for hard scales and another for soft skin, with similarities to human skin differentiation.